Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published:March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like Researchers develop four new regimens to treat people with multidrug-resistant TB meningitis August 18, 2024 New study reveals how GLP-1 receptor agonists enhance preingestive fullness June 27, 2024 Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2 March 2, 2024
Researchers develop four new regimens to treat people with multidrug-resistant TB meningitis August 18, 2024